Seth, in his 2022 review, details that an excess of mortalin aids in the irregular proliferation observed in cancer cells, while inhibiting mortalin promotes oxidative stress, enhances mitochondrial functions, and reduces lifespan in pathologies such as AD, PD, and HIV. This evidence concerns the gene HSPA9 and cancer.